SB-206553
外观
| 识别信息 | |
|---|---|
| |
| CAS号 | 158942-04-2 |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 化学信息 | |
| 化学式 | C17H16N4O |
| 摩尔质量 | 292.34 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
SB-206553是一种含氮有机化合物,分子式C
17H
16N
4O,可作为5-HT2B受體和5-HT2C受體的混合受体拮抗剂[1][2][3],由葛蘭素史克在1990年代为治疗焦虑症而研发[4]。
参考文献
[编辑]- ^ Forbes IT, Ham P, Booth DH, Martin RT, Thompson M, Baxter GS, et al. 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity. Journal of Medicinal Chemistry. July 1995, 38 (14): 2524–30. PMID 7629791. doi:10.1021/jm00014a004.
- ^ Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, et al. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. British Journal of Pharmacology. February 1996, 117 (3): 427–434. PMC 1909304
. PMID 8821530. doi:10.1111/j.1476-5381.1996.tb15208.x.
- ^ Forbes IT, Dabbs S, Duckworth DM, Ham P, Jones GE, King FD, et al. Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists. Journal of Medicinal Chemistry. December 1996, 39 (25): 4966–77. PMID 8960557. doi:10.1021/jm960571v.
- ^ SB 206553. AdisInsight. 13 August 1996 [14 January 2025].